Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    NOTICE OF INTENT TO SOLE SOURCE – QIAGEN

    Sol. 26-000312Special NoticeBETHESDA, MD
    Closed
    STATUS
    Closed
    closed Mar 25, 2026
    POSTED
    Mar 18, 2026
    Publication date
    NAICS CODE
    339112
    Primary industry classification
    PSC CODE
    6515
    Product & service classification

    AI Summary

    The National Institutes of Health intends to award a sole source contract to QIAGEN for reagents and supplies necessary for clinical testing at the NIH Clinical Center. This acquisition is conducted under FAR Part 13, Simplified Acquisition Procedures, and is not open for competition. Interested parties may express their capabilities by March 25, 2026.

    Contract details

    Solicitation No.
    26-000312
    Notice Type
    Special Notice
    Posted Date
    March 18, 2026
    Response Deadline
    March 25, 2026
    NAICS Code
    339112AI guide
    PSC / Class Code
    6515
    Primary Contact
    Kristin Nagashima
    State
    MD
    ZIP Code
    20892
    AI Product/Service
    product

    Description

    This acquisition is for reagents and supplies from QIAGEN for the continued provision of clinical testing at the National Institutes of Health (NIH) Clinical Center (CC) Department of Laboratory Medicine (DLM).

    •             Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

    •             NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

    •             Place of Performance: Bethesda, MD 20892 USA

    POTS: 26-000312

    Description:

    This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

    The National Institutes of Health (NIH) intends to award a fixed price purchase order to QIAGEN, LLC, located at 19300 Germantown Rd, Germantown, MD 20874, on a firm fixed price sole source award basis to provide annual preventative maintenance services to the National Institutes of Health.

    The proposed vendor, QIAGEN, is the sole manufacturer and authorized service provider for the instrumentation. As sole developer and manufacturer of this instrument, QIAGEN is the only vendor from which purchase of reagents and supplies can be made.

    This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

    Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

    Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by March 25, 2026 at 11am EST.

    Key dates

    1. March 18, 2026Posted Date
    2. March 25, 2026Proposals / Responses Due

    AI search tags

    Frequently asked questions

    NOTICE OF INTENT TO SOLE SOURCE – QIAGEN is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.